Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GALK1 | P51570 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4116229 | 1.00 | ALDH1A1 (0.33) | ALDH1A1CYP1A2CYP3A4PKMCYP2C19 | |
| SCHEMBL4127220 | 0.84 | HTT (0.36) | ALDH1A1CYP1A2CYP3A4PKMCYP2C19 | |
| SCHEMBL4127222 | 0.84 | HTT (0.36) | ALDH1A1CYP1A2CYP3A4PKMCYP2C19 | |
| SCHEMBL4125338 | 0.83 | HTT (0.39) | ALDH1A1CYP1A2CYP2C19HTTGALK1 | |
| SCHEMBL13614127 | 0.80 | HTT (0.42) | ALDH1A1CYP1A2CYP3A4PKMCYP2C19 | |
| SCHEMBL13696939 | 0.79 | ALDH1A1 (0.32) | ALDH1A1CYP1A2CYP3A4PKMCYP2C19 | |
| SCHEMBL4621204 | 0.79 | HTT (0.44) | ALDH1A1CYP3A4HTTGALK1 | |
| SCHEMBL4505005 | 0.79 | HTT (0.41) | ALDH1A1HTTGALK1HSD17B10 | |
| SCHEMBL4518577 | 0.78 | HTT (0.40) | ALDH1A1HTTGALK1 | |
| SCHEMBL4512881 | 0.78 | GALK1 (0.52) | ALDH1A1CYP1A2CYP2C19HTTGALK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090221596-A1 | Substtituted aryl oximes | BAYER CROPSCIENCE AG (DE) | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221596-A1 | Substtituted aryl oximes | CYP1A1, PRDX1, CYP1A2 | ALDH1A1 319/4885CYP1A2 3/4885CYP3A4 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.